MEI Pharma Inc reports results for the quarter ended in December - Earnings Summary

Lite Strategy

10/02/2023 24:26

* MEI Pharma Inc  MEIP.OQ  reported quarterly adjusted
earnings of
8 cents​​ per share for the quarter ended in December. The mean
expectation of five analysts for the quarter was for a loss
of 15 cents per share.
    * Revenue rose 79.6% to $32.74 million from a year ago;
analysts
expected $5.29 million. 
    * MEI Pharma Inc's reported EPS for the quarter was 8
cents​.
    * The mean earnings estimate of analysts had risen by
about 16.7%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * MEI Pharma Inc shares had risen by 41.6% this quarter.
    * The company reported quarterly net income of $10.25
million.
    * Wall Street's median 12-month price target for MEI Pharma
Inc is
$3.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
10 at 12:26 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.15          0.08           Beat
 Sep. 30 2022      -0.14          -0.12          Beat
 Jun. 30 2022      -0.19          -0.12          Beat
 Mar. 31 2022      -0.18          -0.07          Beat